Tip: Activate javascript to be able to use all functions of our website

Improving health outcomes globally

On behalf of the Federal Ministry for Economic Cooperation and Development KfW is investing EUR 10 million in the Global Health Investment Fund (GHIF) guaranteed by the Bill & Melinda Gates Foundation. The GHIF, which has a target size of USD 100 million, is an innovative financing instrument in the health sector and is also attractive for private investors.

The GHIF funds the development and launch of new medicines, vaccines, diagnostic instruments and family planning products in developing countries. In the later stages of clinical studies pharmaceutical companies, research institutes and government institutions are able to apply for funding to use these products to fight disease. The focus is on health products which can be used to treat diseases prevalent among poorer sections of the population which pharmaceutical companies do not have an incentive to invest in combatting in the absence of subsidies.

Positions and projects

As of July 2015


KfW Group


Palmengartenstrasse 5-9

60325 Frankfurt am Main



+49 69 7431 44 00


+49 69 74 31 32 66


Press release from 23 September 2013

Improving health outcomes globally: KfW to invest in the GHIF of the Bill & Melinda Gates Foundation

Read more

Transparency Portal

Disclosure of our Data regarding Development Financing - Sorted by countries, sectors and results

Read more

The international financier of KfW



KfW Development Bank

Development Research

Background analyses on development policy topics such as poverty and MDGs, evaluation of the effectiveness of development cooperation, summaries of current trends and debates, as well as opinions from renowned development researchers.

Read more